These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26150847)

  • 1. Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI.
    Dogan NB; Ozpelit E; Akdeniz S; Bilgin M; Baris N
    Pak J Med Sci; 2015; 31(3):576-81. PubMed ID: 26150847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Wang JW; Chen YD; Wang CH; Yang XC; Zhu XL; Zhou ZQ
    Cardiology; 2013; 124(3):153-60. PubMed ID: 23485798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention.
    Badran HM; Fatah AA; Soltan G
    J Clin Transl Res; 2020 Jul; 6(1):20-26. PubMed ID: 32935070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of pre-primary percutaneous coronary intervention β blocker use on the no-reflow phenomenon in patients with acute myocardial infarction].
    Wang J; Chen Y; Wang C; Zhu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):822-6. PubMed ID: 25547444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients.
    Bayramoğlu A; Taşolar H; Kaya A; Tanboğa İH; Yaman M; Bektaş O; Günaydın ZY; Oduncu V
    J Interv Cardiol; 2018 Apr; 31(2):144-149. PubMed ID: 29193382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk score for no reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Wang JW; Zhou ZQ; Chen YD; Wang CH; Zhu XL
    Clin Cardiol; 2015 Apr; 38(4):208-15. PubMed ID: 25892404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.
    Zhang H; Qiu B; Zhang Y; Cao Y; Zhang X; Wu Z; Wang S; Mei L
    Med Sci Monit; 2018 Jul; 24():4528-4535. PubMed ID: 29961077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention.
    Abdi S; Rafizadeh O; Peighambari M; Basiri H; Bakhshandeh H
    Res Cardiovasc Med; 2015 May; 4(2):e25414. PubMed ID: 26393231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
    Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
    Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture.
    Soeda T; Higuma T; Abe N; Yamada M; Yokoyama H; Shibutani S; Ong DS; Vergallo R; Minami Y; Lee H; Okumura K; Jang IK
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):103-110. PubMed ID: 26800769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality.
    Del Turco S; Basta G; De Caterina AR; Sbrana S; Paradossi U; Taddei A; Trianni G; Ravani M; Palmieri C; Berti S; Mazzone A
    Int J Cardiol; 2019 Sep; 290():34-39. PubMed ID: 31079969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention.
    Shakiba M; Salari A; Mirbolouk F; Sotudeh N; Nikfarjam S
    J Tehran Heart Cent; 2020 Apr; 15(2):50-56. PubMed ID: 33552194
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.